These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Navarro M, Negre S, Matoses ML, Golombek SG, Vento M. Acta Paediatr; 2009 Jul; 98(7):1214-7. PubMed ID: 19397554 [Abstract] [Full Text] [Related]
3. Necrotizing enterocolitis in a term neonate following intravenous immunoglobulin therapy. Krishnan L, Pathare A. Indian J Pediatr; 2011 Jun; 78(6):743-4. PubMed ID: 21243534 [Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Nasseri F, Mamouri GA, Babaei H. Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357 [Abstract] [Full Text] [Related]
5. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease. Corvaglia L, Legnani E, Galletti S, Arcuri S, Aceti A, Faldella G. J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154 [Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Figueras-Aloy J, Rodríguez-Miguélez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet-Mussons F, Carbonell-Estrany X. Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572 [Abstract] [Full Text] [Related]
12. Correspondence in regard to necrotising enterocolitis in a term neonate following intravenous immunoglobulin therapy. Thukral A, Agarwal R. Indian J Pediatr; 2012 Dec; 79(12):1676-7; author's reply p.1677. PubMed ID: 22477040 [No Abstract] [Full Text] [Related]
13. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care]. Senterre T, Minon JM, Rigo J. Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989 [Abstract] [Full Text] [Related]
15. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility]. Li ZH, Wang J, Chen C. Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522 [Abstract] [Full Text] [Related]
16. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn. Walsh SA, Yao N, El-Khuffash A, Twomey A, Molloy EJ. Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249 [Abstract] [Full Text] [Related]
18. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial. Santos MC, Sá C, Gomes SC, Camacho LA, Moreira ME. Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285 [Abstract] [Full Text] [Related]